MicroPort Scientific (MicroPort Scientific) 5-Year EBITDA Growth Rate : 0.00% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is MicroPort Scientific 5-Year EBITDA Growth Rate?

MicroPort Scientific's EBITDA per Share for the six months ended in Dec. 2023 was $-0.20.

During the past 3 years, the average EBITDA Per Share Growth Rate was -52.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of MicroPort Scientific was 27.30% per year. The lowest was -52.60% per year. And the median was 11.40% per year.

Competitive Comparison of MicroPort Scientific's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, MicroPort Scientific's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort Scientific's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort Scientific's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MicroPort Scientific's 5-Year EBITDA Growth Rate falls into.

MicroPort Scientific 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

MicroPort Scientific (OTCPK:MCRPF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

MicroPort Scientific 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort Scientific (MicroPort Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (OTCPK:MCRPF) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

00853:Hong Kong MSK:Germany

Address

1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203

Website

https://www.microport.com

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.

MicroPort Scientific (MicroPort Scientific) Headlines

From GuruFocus

MicroPort Orthopedics and Medacta Agree to Settlement on Patent Claims

By PRNewswire PRNewswire • 07-14-2021

Firehawk® Clinical Data From The TARGET AC European Clinical Trial Has Been Accepted For Publication In The Prestigious Medical Journal The Lancet

By PRNewswire PRNewswire • 09-04-2018